Skip Navigation Links
Home
Products
Events
Resources
Support
Investors
Contact

SciFiGPsmJewelCase.jpg  TinyGastroLogo.jpg
Advanced absorption, pharmacokinetic, and pharmacodynamic simulation software
SciFiAPSmJewelCase3.jpg TinyADMETpredLogo.jpg
ADME-Tox property prediction and QSAR model-building
MCS2.0WebGraphicSM.jpg

TinyMedChemLogo.jpg
Advanced data mining and molecule design


smDDDPlus4.0JewelCase.jpg  
MCDesignerCaseSM2.jpg

TinyDDDPlusLogo.jpg
Simulation of in vitro dissolution experiments



MCDLogoTiny2.jpg
FREE! Chemical structure drawing and ADMET property prediction

 
 
Simulations Plus Reports First Quarter FY2012 Financial Results
LANCASTER, CA, January 18, 2012 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical disc...
Read More
Simulations Plus Sets Date for 1st Quarter 2012 Earnings Release and Conference Call
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of software and consulting services for pharmaceutical R&...
Read More

1st Qtr. Financial Results and Conference Call

You may view the 1st Qtr. 2012 financial results and conference call by clicking on Investors on the navigation bar above, then going to Conference Call. Windows Media Player is required. 
 

New article written by our CEO

To read the invited "Perspective" article recently published in the Journal of Computer-Aided Molecular Design: "If we designed airplanes like we design drugs..." written by our CEO Walt Woltosz, please click here.


Another new article written by our Director of Life Sciences and Research Fellow
To read the invited "Perspective" article
recently published in the Journal of Computer-Aided Molecular Design: "Lions and tigers and bears, oh my! Three barriers to progress in computer-aided molecular design", please click here.